This work is licensed under a
Creative Commons Attribution 4.0 International License
 V.V. Kolta, V.K. Dalavai, V.R. Chanduri, Synthesis and biological activity studies of some novel pyrazoline derivatives, Der Pharma Chemica. 4(5) (2012) 2003-(2008).
 M. Reddy et al., Synthesis, characterization and antimicrobial Activity of certain novel aryl hydrazone pyrazoline-5-ones containing thiazole moiety, Advanced Pharm. Bull. 3(1) (2013) 153-159.
 N. V Kavitha et al., Synthesis and antimicrobial activities of some new pyrazole derivatives, Der Pharma Chemica. 3(4) (2011) 55-62.
 M. Amir, H. Kumar, S. Khan, Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents, Bioorg. and Med. Chem. Lett. 18 (2008) 918-922.DOI: 10.1016/j.bmcl.2007.12.043
 S.M. El-Moghazy, F.F. Barsoum, H.M. Abdel-Rahman, A.A. Marzouk, Synthesis and anti-inflammatory activity of some pyrazole derivatives, Med. Chem. Res. 21 (2012) 1722-1733.DOI: 10.1007/s00044-011-9691-4
 M. Karabacak et al., Synthesis and evaluation of new pyrazoline derivatives as potential anticancer agents, Molecules. 20 (2015) 19066-19084.DOI: 10.3390/molecules201019066
 M. Shaharyar, M.M. Abdullah, M.A. Bakht, J. Majeed, Pyrazoline bearing benzimidazoles: Search for anticancer agent, Eur. J. Med. Chem. 45 (2010) 114-119.DOI: 10.1016/j.ejmech.2009.09.032
 S. Gok, M. Demet, A. Ozdemir, G. Zitouni, Evaluation of antidepressant-like effect of 2-pyrazoline derivatives, Med. Chem. Res. 19 (2010) 94-101.DOI: 10.1007/s00044-009-9176-x
 M.A. Ali, M. Shaharyar, A. A Siddiqui, Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives, Eur. J. Med. Chem. 42(2) (2007) 268-275.DOI: 10.1016/j.ejmech.2006.08.004
 P.T. Chovatia et al., Synthesis and selective antitubercular and antimicrobial inhibitory activity of 1-acetyl-3, 5-diphenyl-4, 5-dihydro-(1H)-pyrazole derivatives, J. Serb. Chem. Soc. 71(7) (2007) 713-720.DOI: 10.2298/jsc0607713c
 F. Hayat, A. Salahuddin, S. Umar, A. Azam, Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail, Eur. J. of Med. Chem. 45 (2010) 4669-4675.DOI: 10.1002/chin.201103125
 D.M. Martins et al., Antioxidant potential of new pyrazoline derivatives to prevent oxidative damage., Basic and Clin. Pharmacol. and Toxicol. 104(2) (2009) 107-112.
 V. H. Babu, C. Sridevi, A. Joseph, K. K. Srinivasan, Synthesis and biological evaluation of some novel pyrazolines, Ind. J. Pharm. Sci. 69 (2008) 470-473.DOI: 10.4103/0250-474x.34569
 S. Ovais et al., Synthesis and biological evaluation of some new pyrazoline substituted benzenesulfonylurea/thiourea derivatives as anti- hyperglycemic agents and aldose reductase inhibitors, Eur. J. Med. Chem. 80 (2014) 209-217.DOI: 10.1016/j.ejmech.2014.04.046
 S. Ozdemir et al., Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives, Eur. J. Med. Chem. 42 (2007) 373-379.
 S.G. Kucukguzel et al., Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines. Eur. J. Med. Chem. 35 (2000) 761-771.DOI: 10.1016/s0223-5234(00)90179-x
 F. Chimenti et al., Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3, 5-diphenyl-4, 5-dihydro-(1H)-pyrazole derivatives, Eur. J. Med. Chem. 43 (2008) 2262-2267.DOI: 10.1002/chin.200928106
 Infectious Society of America, Statement of the IDSA Concerning Bioshield II: Responding to a Diseases Ever-Changing Threat, IDSA, Alexandria, Va, USA, (2004).
 J.S. Bradley, R. Guidos, S. Baragona, Anti-infective research and development-problems, challenges and solutions, The Lancet Infectious Diseases. 7(1) (2007) 68-78.DOI: 10.1016/s1473-3099(06)70689-2
 P.N. Patel, D.C. Karia, Synthesis and bioactivity evaluation of novel biphenyl thioxo pyrimidines as potent antimicrobial agent, Der Pharma Chemica. 7 (2015) 427-433.